Lattice Medical key facts
as of Oct 2026- Operator of a medical device company intended to help manufacture and design soft tissue reconstruction devices for breast reconstruction.
- Lattice Medical is valued at approximately $11.0M as of Oct 2026 (last reported valuation).
- It has raised $55.6M; the latest was Later Stage VC ($50.4M) in Oct 2025.
- Notable investors include Bpifrance, European Innovation Council, MedTech Innovator, La French Tech, European Regional Development Fund (Brandenburg) — 19 tracked in total.
- Status: Privately Held (backing).
Lattice Medical's last reported valuation, Oct 2022. Nothing priced has surfaced since.
- ·The complete investor list: 19 names
- ·Watch Lattice Medical: the Monday email on marks, rounds and moves
Lattice Medical funding rounds
No funding rounds for Lattice Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Lattice Medical
19+Lattice Medical valuation
Lattice Medical's last reported valuation was $11 million in Oct 2022. No priced round, secondary trade or fund mark has surfaced since.
Lattice Medical investors
19 investors are on record for Lattice Medical, including Bpifrance, European Innovation Council, MedTech Innovator and La French Tech.
About Lattice Medical
Operator of a medical device company intended to help manufacture and design soft tissue reconstruction devices for breast reconstruction. The company specializes in implants for breast reconstruction after cancer that help in personalized reconstruction with a single surgery, enabling health professionals to reduce surgery time, minimize invasiveness, and minimize pain.
- Sector
- Healthcare
- HQ
- Loos, France
- Founded
- 2017
- Employees
- 37
- Website
- lattice-medical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.